Reanalysis for PK Reason: Gone with the Wind [Bioanalytics]

posted by Ohlbe – France, 2020-07-16 19:15 (101 d 04:40 ago) – Posting: # 21721
Views: 2,293

Dear Helmut,

» » » According to the current guidelines (EMA 2011, FDA 2018, ICH draft 2019) it is no more acceptable. IMHO, bad science.
» »
» » Agreed.
»
» Agreed on what? That is not acceptable or that it is bad science?

That it is bad science, of course ! To accept as a matter of principle data which are obviously incorrect, and to refuse as a matter of principle for these data to be corrected, is something I fail to understand.

I understand that assessors may be suspicious if there were some re-analyses for PK reasons. If the study is only borderline passing, they always have the possibility to perform (or ask for) a statistical analysis with the original data. Depending on the outcome, they may ask for an inspection.

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,179 posts in 4,414 threads, 1,475 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Sunday 22:55 CET (Europe/Vienna)

Mediocrity knows nothing higher than itself,
but talent instantly recognizes genius.    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5